Operon CEO has recognize by medget
Recognized for exceptional leadership and innovation, the CEO of Operon Strategist has achieved an impressive milestone by Medgate.
PUNE, MAHARASHTRA, INDIA, July 17, 2023/EINPresswire.com/ — Mr. Anil Chaudhari, CEO of Operon Strategist, a leading provider of healthcare and regulatory consulting services, has been named one of the top 50 Healthcare and Medtech Leaders by Medgate, a prestigious industry recognition platform. Operon Strategist provides regulatory consultancy for medical devices such as USFDA, CE marking, UKCA, SFDA registration, CDSCO registration, turnkey project, ISO 13485 etc. working globally since 11 years with a presence in over 32 countries.
Medgate’s Top 50 Healthcare and Medtech Leaders list acknowledges individuals who have demonstrated outstanding leadership, innovation, and contributions to the healthcare and medical technology sectors. This prestigious accolade recognizes Mr. Anil Chaudhari’s exceptional achievements and his significant impact on industry.
As the CEO of Operon Strategist, Mr. Anil Chaudhari has played a pivotal role in driving the company’s success and establishing it as a trusted name in regulatory consulting. Under his visionary leadership, Operon Strategist has consistently provided innovative solutions to clients, enabling them to navigate complex regulatory landscapes and bring life-saving medical devices products to market.
Anil Chaudhari’s recognition as one of the top 50 Healthcare and Medtech Leaders by Medgate reflects his profound expertise, strategic vision, and commitment to advancing the healthcare industry. His comprehensive understanding of regulatory requirements and his ability to anticipate industry trends have been instrumental in guiding clients towards success in an ever-evolving regulatory environment.
Komal Patil
operon Strategist
09370283428
operonstrategist5@gmail.com
